Procedure
Re-resection
Re-resection is a medical procedure with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
1
33%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 3Large-scale testing
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Active, not recruiting1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 21 (50.0%)
Phase 31 (50.0%)
Trials by Status
active_not_recruiting133%
recruiting133%
unknown133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_2
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
NCT03743662
recruiting
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
NCT06283927
unknownphase_3
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma
NCT01833286
Clinical Trials (3)
Showing 3 of 3 trials
NCT03743662Phase 2
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
NCT06283927
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
NCT01833286Phase 3
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3